Gapping up
In reaction to strong earnings/guidance: ARAY +9.6%, BRCD +4.9%, UEPS +4.9%, AVNW +3.6%, CRM +3.2%, FL +2.5%, MSON +1.6%, GPS +0.7%
M&A news:SPIL +33.2% (Advanced Semiconductor Engineering (ASX) to commence tender offers for Taiwan and U.S. shares of SPIL ), RPTP +8.2% (to acquire Quinsair from Tripex Pharmaceuticals for $68.4 mln upfront; co reaffirmed FY15 guidance)
Select metals/mining stocks trading higher: AU +6.2%, GFI +2%, GG +1.4%, AEM +1.2%, ABX +1.1%, GDX +1%
Other news: IMUC +9.8% (issues a letter to shareholders on its progress in advancing ICT-107 to a Phase 3 Registrational Trial), AAC +5.6% (last night's conference call on the California Legal case and preview its Q3 operations; Deerfield Mgmt discloses 6.43% passive stake in 13G filing), ZIOP +1.7% (ZIOPHARM discloses that on August 17, it, Intrexon (XON) and MD Anderson entered into a research and development agreement to formalize the scope and process of the previously announced license agreement ), IOSP +1.6% (to replace BRLI in the S&P SmallCap 600), Financial Officer of its Match Group subsidiary) IACI +1.5% (announced that Gary Swidler has been appointed as Chief Financial Officer of its Match Group subsidiary)
Analyst comments: ABB +0.8% (upgraded to Buy at HSBC
)
In reaction to strong earnings/guidance: ARAY +9.6%, BRCD +4.9%, UEPS +4.9%, AVNW +3.6%, CRM +3.2%, FL +2.5%, MSON +1.6%, GPS +0.7%
M&A news:SPIL +33.2% (Advanced Semiconductor Engineering (ASX) to commence tender offers for Taiwan and U.S. shares of SPIL ), RPTP +8.2% (to acquire Quinsair from Tripex Pharmaceuticals for $68.4 mln upfront; co reaffirmed FY15 guidance)
Select metals/mining stocks trading higher: AU +6.2%, GFI +2%, GG +1.4%, AEM +1.2%, ABX +1.1%, GDX +1%
Other news: IMUC +9.8% (issues a letter to shareholders on its progress in advancing ICT-107 to a Phase 3 Registrational Trial), AAC +5.6% (last night's conference call on the California Legal case and preview its Q3 operations; Deerfield Mgmt discloses 6.43% passive stake in 13G filing), ZIOP +1.7% (ZIOPHARM discloses that on August 17, it, Intrexon (XON) and MD Anderson entered into a research and development agreement to formalize the scope and process of the previously announced license agreement ), IOSP +1.6% (to replace BRLI in the S&P SmallCap 600), Financial Officer of its Match Group subsidiary) IACI +1.5% (announced that Gary Swidler has been appointed as Chief Financial Officer of its Match Group subsidiary)
Analyst comments: ABB +0.8% (upgraded to Buy at HSBC
)